Biologic Treatment Sequences for Plaque Psoriasis: A Cost-Utility Analysis Based on 10 Years of Dutch Real-World Evidence From BioCAPTURE

British Journal of Dermatology - United Kingdom
doi 10.1111/bjd.16613
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Real‐World Evidence of Secukinumab in Psoriasis Treatment – A Meta‐Analysis of 43 Studies

Journal of the European Academy of Dermatology and Venereology
DermatologyInfectious Diseases
2020English

A UK-Based Cost-Utility Analysis of Indacaterol, a Once-Daily Maintenance Bronchodilator for Patients With COPD, Using Real World Evidence on Resource Use

Applied Health Economics and Health Policy
MedicineHealth PolicyEconomicsEconometrics
2013English

Cost Per Responder for Ixekizumab and Other Biologic Drugs Approved for the Treatment of Moderate-To-Severe Plaque Psoriasis in Italy

Global and Regional Health Technology Assessment
Health Policy
2019English

Pmu49 - Health Insurance Cost of Psoriasis in Hungary: Cost of Illness Study Based on Real World Data

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Psy149 - Iqvia Patient Data Assessment: Real World Evidence in the Management of Moderate-To-Severe Plaque Psoriasis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Psy29 - Real-World Discontinuation of Biological Treatments in Moderate-To-Severe Plaque Psoriasis Over the First 5 Years of Treatment – A Literature Review of Drug Survival

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Algorithm for Selecting Ideal Biologic Treatment for Psoriasis

Journal of Clinical & Experimental Dermatology Research
2015English

Psy103 - Modelling Average Cost and Cost-Per-Responder for Biological Treatments for Moderate-To-Severe Plaque Psoriasis With Dose Escalation and Real-World Drug Survival

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Infliximab for the Treatment of Plaque Psoriasis

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy